Compare TCBS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBS | ECOR |
|---|---|---|
| Founded | 1934 | 2005 |
| Country | United States | United States |
| Employees | 71 | N/A |
| Industry | Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.6M | 49.1M |
| IPO Year | 2021 | 2018 |
| Metric | TCBS | ECOR |
|---|---|---|
| Price | $16.83 | $6.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 1.5K | ★ 51.3K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 327.27 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $16.80 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $15.10 | $4.16 |
| 52 Week High | $20.00 | $8.30 |
| Indicator | TCBS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 50.48 |
| Support Level | $16.79 | $4.55 |
| Resistance Level | $17.13 | $6.61 |
| Average True Range (ATR) | 0.16 | 0.49 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 65.63 | 41.61 |
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.